The goal of this Program Project application is to further the
understanding of the human neurobiology of nicotine by examining brain
mechanisms and behaviors that define nicotine dependence. it consists of
4 closely coordinated research projects adopting 3 approaches to further
these aims: Imaging--to specify nicotine's locus of action in the normal
human brain using PET; Psychopharmacology--to examine how cognitive
deficits associated with psychiatric cofactors can reinforce (and
overdetermine) smoking; and Behavioral genetics -- to increase knowledge
about the heritability of nicotine's reinforcing effects via behavioral
genetics research on individual differences in nicotine sensitivity and
metabolism. Research Projects will test these hypotheses: Project 1:
Acute nicotine doses will cause reliable regional changes in cerebral
bloodflow and metabolism; Project 2: Where nicotine withdrawal effects
overlap with ADHD symptomatology, affected individuals will experience
severe and persistent nicotine abstinence symptomatology, which will be
reduced by methylphenidate administration; neither diagnostic nor
medication status will affect nicotine sensitivity; Project 3: Genetic
influences on nicotine use can be partitioned into influences associated
with cofactors (depression, childhood conduct disorder, ADHD) and
influences associated with nicotine sensitivity; Project 4: Individual
differences in nicotine disposition and kinetics are heritable; metabolic
differences can be differentiated from environmental factors associated
with smoking. Support will be provided by 3 Cores: The Administrative
Core will facilitate communication, integration, and shared mission as
well as ensure quality control; oversight will be provided by an External
Advisory Board, which will meet annually to review progress and policy,
and an Internal Advisory board, which will meet quarterly to advise on
progress and use of resources. The Assessment Services Core will provide
standardized assessment of nicotine dependence and cofactors across
projects. The Assay Services Core will conduct nicotine/cotinine and
other assays needed by the Research Projects. Health Significance:
Cigarette smoking is associated with over 400,000 premature deaths per
year in the U.S. Over the past decade, there has been substantial
progress in defining mechanisms for nicotine reinforcement at the
molecular and animal level; understanding aat the human level, however,
has lagged behind. The long-term objective is to help redress this
deficiency. A larger implication is that the widespread use of nicotine
and its potent pharmacology make it an excellent model of drug abuse in
general.
Error Notice
The database may currently be offline for maintenance and should be operational soon. If not, we have been notified of this error and will be reviewing it shortly.
We apologize for the inconvenience.
- The DCCPS Team.